Ming-He Huang - Concepedia

Author

Ming-He Huang

The University of Texas Medical Branch at Galveston

Also Known As

M. H. Huang, Ming-He Huang, Ming-he Huang

Publications

883

Citations

H-Index

Concepts

All Affiliations

The University of Texas Medical Branch at Galveston

About

Ming-He Huang is an author at The University of Texas Medical Branch at Galveston specializing in medicine, cardiovascular pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	671
2	Health Sciences	2	2	32
3	Public Health	1	1	17
4	Social Sciences	1	1	17
5	Anesthesia	1	1	141

Ming-He Huang

Publications

871

Citations

H-Index

Page 1

	Year	Citations
Augmentation of Myocardial Production of 15-Epi-Lipoxin-A <sub>4</sub> by Pioglitazone and Atorvastatin in the Rat Yochai Birnbaum, Yumei Ye, Yu Lin, Circulation	2006	168
Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent <i>S</i>-nitrosylation of cyclooxygenase-2 Shaul Atar, Yumei Ye, Yu Lin, American Journal of Physiology-Heart and Circulatory Physiology Heart FailureCardiac AnaesthesiaLipid PeroxidationCardiovascular PharmacologyInos Activity	2005	141
The Cardioprotective Effect of a Statin and Cilostazol Combination: Relationship to Akt and Endothelial Nitric Oxide Synthase Activation Saraswathy Manickavasagam, Yumei Ye, Yu Lin, Cardiovascular Drugs and Therapy InflammationCardioprotective EffectHeart FailureMolecular PhysiologyCardiovascular Disease	2007	86
The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation Ramanna Merla, Yumei Ye, Yu Lin, American Journal of Physiology-Heart and Circulatory Physiology Adenosine ReceptorsCardiovascular PharmacologyCellular PhysiologyInflammationSignaling Pathway	2007	80
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions Yumei Ye, Yu Lin, Shaul Atar, American Journal of Physiology-Heart and Circulatory Physiology Heart FailureCardiovascular PharmacologyPharmacotherapyCox-2 ExpressionCardiovascular Toxicity	2006	74
Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination Yumei Ye, Yu Lin, Regino Perez‐Polo, American Journal of Physiology-Heart and Circulatory Physiology Heart FailureCardiovascular PharmacologyPharmacotherapyOxidative StressMolecular Pharmacology	2007	53
Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart Yochai Birnbaum, Yumei Ye, Yu Lin, Prostaglandins & Other Lipid Mediators OxysterolCardiovascular DiseaseAtorvastatin InductionMedicineLipid Peroxidation	2006	49
Enhanced Cardioprotection Against Ischemia-Reperfusion Injury with Combining Sildenafil with Low-Dose Atorvastatin Salvatore Rosanio, Yumei Ye, Shaul Atar, Cardiovascular Drugs and Therapy ThrombosisHeart FailureCombining SildenafilCardiovascular DiseaseCardiovascular Pharmacology	2006	44
Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin Yochai Birnbaum, Yu Lin, Yumei Ye, American Journal of Physiology-Heart and Circulatory Physiology Intravenous AsaReperfusion BluntsCardiovascular PharmacologyPharmacotherapyCoronary Artery Disease	2007	42
Mediating δ-opioid-initiated heart protection via the β<sub>2</sub>-adrenergic receptor: role of the intrinsic cardiac adrenergic cell Ming-He Huang, Hui-Qun Wang, William R. Roeske, American Journal of Physiology-Heart and Circulatory Physiology Cardiac MuscleCardiovascular PharmacologyPharmacotherapyExperimental PharmacologyCellular Physiology	2007	38

Page 1